Melpomeni Fani is a Professor of Radiopharmaceutical Chemistry at the University of Basel, Switzerland. She is working on targeted radiopharmaceuticals for oncological diseases in preclinical and clinical settings. She focuses on the use of peptides in combination with different radioisotopes to achieve all-in-one diagnosis and therapy (theranostics). Her group is practically involved in the entire spectrum from peptide and chelation/bioconjugation chemistry to radiochemistry; in vitro, in vivo and imaging studies (PET/CT and SPECT/CT); and clinical translation. Prof. Fani is a chemist in training, and she holds a Master's degree in Biochemistry and a PhD in Radiopharmacy from the University of Athens, Greece.